Analyst price target range
Abivax Price Target: $163.58 Average
Direct answer
Abivax's average price target is $163.58.
The verified analyst range runs from $142.00 to $181.00.
The low target implies +64%, the high target implies +109%, and the range spans 45% of the current price.
Forecast evidence checked November 2, 2026.
Get free Abivax email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $86.59
- Average price target
- $163.58
- High price target
- $181.00
- Low price target
- $142.00
- Low target gap
- +64%
- Target upside
- +88.9%
- High target gap
- +109%
- Target range width
- 45%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- November 2, 2026
- Valid through
- November 9, 2026
Explore related company data
Read the frequently asked questions.
What is Abivax's average price target?
Abivax's verified average price target is $163.58. The target range is $142.00 to $181.00.
How far are Abivax's low and high targets from the recorded price?
The low target implies +64%, while the high target implies +109%.
How many analysts are included in Abivax's consensus?
The verified consensus includes 12 analysts.
How is Abivax's target upside or downside calculated?
The average target of $163.58 is divided by the recorded price of $86.59, then one is subtracted to produce +88.9%. This does not guarantee a future return.
When was Abivax's analyst forecast verified?
The data was verified on 2026-11-02. The dataset is valid through 2026-11-09.